Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?

作者信息

Gabriel Sherine E

出版信息

Arthritis Rheum. 2008 Mar;58(3):637-40. doi: 10.1002/art.23280.

DOI:10.1002/art.23280

PMID:18311805

Abstract

摘要

相似文献

Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?

Arthritis Rheum. 2008 Mar;58(3):637-40. doi: 10.1002/art.23280.

Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

Arthritis Rheum. 2008 Mar;58(3):667-77. doi: 10.1002/art.23281.

New drugs for rheumatoid arthritis.

N Engl J Med. 2004 May 20;350(21):2167-79. doi: 10.1056/NEJMra032906.

Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.

J Rheumatol. 2006 May;33(5):831-3.

Tumor necrosis factor inhibitors for rheumatoid arthritis.

N Engl J Med. 2006 Aug 17;355(7):704-12. doi: 10.1056/NEJMct055183.

Anti-TNF-alpha therapies: they are all the same (aren't they?).

Rheumatology (Oxford). 2005 Mar;44(3):271-3. doi: 10.1093/rheumatology/keh483. Epub 2004 Nov 23.

Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.

J Rheumatol. 2009 Dec;36(12):2847-8. doi: 10.3899/jrheum.090307.

Biologic therapy for rheumatoid arthritis.

N Engl J Med. 2000 Nov 30;343(22):1640-1. doi: 10.1056/NEJM200011303432210.

Tumor necrosis factor-alpha blockade and the risk of vasculitis.

J Rheumatol. 2004 Oct;31(10):1885-7.

Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy.

Am J Med. 2004 Mar 1;116(5):305-11. doi: 10.1016/j.amjmed.2003.09.039.

引用本文的文献

Disease and Treatment-Specific Complications of Behçet Syndrome.

Curr Rheumatol Rep. 2024 Jan;26(1):1-11. doi: 10.1007/s11926-023-01124-7. Epub 2023 Nov 23.

Polymeric Hydrogels for Controlled Drug Delivery to Treat Arthritis.

Pharmaceutics. 2022 Feb 28;14(3):540. doi: 10.3390/pharmaceutics14030540.

Cardiotoxicity in Biological Agent-Targeted Therapy for Rheumatoid Arthritis: ADR Signal Mining and Analysis of Food and Drug Administration Adverse Event Reporting System Database.

Front Pediatr. 2021 Oct 12;9:716648. doi: 10.3389/fped.2021.716648. eCollection 2021.

Cardiac rehabilitation in a patient with ankylosing spondylitis: A single-program, double-effect.

Turk J Phys Med Rehabil. 2018 May 2;65(2):194-197. doi: 10.5606/tftrd.2019.2401. eCollection 2019 Jun.

Current Therapeutic Options in the Treatment of Rheumatoid Arthritis.

J Clin Med. 2019 Jun 28;8(7):938. doi: 10.3390/jcm8070938.

Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

Int J Mol Sci. 2018 Jun 12;19(6):1739. doi: 10.3390/ijms19061739.

Efficient and Non-Toxic Biological Response Carrier Delivering TNF-α shRNA for Gene Silencing in a Murine Model of Rheumatoid Arthritis.

Front Immunol. 2016 Aug 19;7:305. doi: 10.3389/fimmu.2016.00305. eCollection 2016.

Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.

Clin Rev Allergy Immunol. 2017 Jun;52(3):323-332. doi: 10.1007/s12016-016-8566-3.

Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Heart Fail Clin. 2014 Apr;10(2):339-52. doi: 10.1016/j.hfc.2013.10.003. Epub 2014 Jan 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr
超能文献

Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Suppr超能文献

Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Suppr
超能文献